Loading...
Loading...
Among the 7 tracked institutional investors we monitor, SKYE (Skye Bioscience, Inc.) is held with a combined value of $2.14M across 3,004,239 shares. The largest holder is BAKER BROS. ADVISORS LP with a position worth $1.09M. 2 funds opened new positions in the most recent quarter. 3 funds reduced their position.
Total Institutional Value
$2.14M
Total Shares Held
3,004,239
Institutional Holders
7
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | $1.09M | 0.01% | - |
| 2 | VANGUARD GROUP INC | $662.09K | 0.00% | - |
| 3 | BlackRock, Inc. | $161.45K | 0.00% | -18.6% |
| 4 | MILLENNIUM MANAGEMENT LLC | $137.64K | 0.00% | -23.1% |
| 5 | STATE STREET CORP | $51.19K | 0.00% | -2.0% |
| 6 | TWO SIGMA ADVISERS, LP | $30.72K | 0.00% | New |
| 7 | FMR LLC | $1 | 0.00% | New |
As of the latest SEC 13F filings, BAKER BROS. ADVISORS LP is the largest institutional holder of SKYE with a position worth $1.09M, representing 0.01% of their portfolio. In total, 7 institutional investors hold SKYE with a combined value of $2.14M.
In the most recent quarter, 2 funds opened a new position in SKYE. Additionally, 3 reduced their positions.
Institutional investors hold $2.14M worth of SKYE stock across 7 positions. The largest institutional holder is BAKER BROS. ADVISORS LP with $1.09M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SKYE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SKYE positions.
| 2026-09-24 |
| 25.9% | 2026-08-18 |
SEC Schedule 13D (activist) and 13G (passive) filings for SKYE. Filed when an investor acquires 5%+ ownership.
Last Close
$1.63
2026-10-21
YTD
-76.8%
1% of 52-week range